机器人Warshaw技术远端胰腺切除术短期预后优于腹腔镜:倾向匹配队列研究
该回顾性队列纳入490例微创远端胰腺切除术患者,经1:1倾向匹配分析比较Kimura、Warshaw及联合脾切除的短期结局。机器人SPDP较腹腔镜SPDP脾梗死率更低、手术时间更短、术后住院更短;Warshaw技术与腹腔镜是脾梗死的独立预后因素。
要点
- 机器人SPDP较腹腔镜SPDP脾梗死率更低、手术时间和住院更短。
- Kimura组CDC≥III并发症、术后胰腺出血和90天再入院高于Warshaw组。
- Warshaw技术和腹腔镜入路是脾梗死的独立预后因素。
核心结论
- 机器人辅助Warshaw技术行微创保脾远端胰腺切除术可能具有更好的效率与安全性。
研究设计与样本
- 单中心回顾性分析2020年1月至2024年5月连续490例微创远端胰腺切除术病例,并行1:1倾向评分匹配。
主要发现
- 倾向匹配后Kimura组CDC≥III发生率为6.3% vs 0.7%(p=0.010),高于Warshaw组。
- Kimura组术后胰腺出血发生率为4.2% vs 0%(p=0.039),高于Warshaw组。
- Kimura组90天内再入院率为4.2% vs 0%(p=0.039),高于Warshaw组。
- Kimura组脾梗死发生率为6.3% vs 31.3%(p<0.01),低于Warshaw组。
- 机器人SPDP组脾梗死率为7.6% vs 27.5%(p<0.01)、手术时间145 vs 175 min(p<0.01)、术后住院6 vs 8天(p<0.01),均优于腹腔镜SPDP组。
关键数值与推荐
- 倾向匹配后SPDP组胸腔积液发生率为5.6% vs 16.8%(p=0.009),低于DPS组。
- 单因素分析显示肿瘤直径、手术时间、Warshaw技术和腹腔镜手术是脾梗死的预后因素。
- 多因素分析显示Warshaw技术和腹腔镜入路是脾梗死的独立预后因素。
临床怎么用
- 微创保脾远端胰腺切除术中可优先考虑机器人辅助Warshaw技术以降低脾梗死风险。
- 选择Kimura技术时需警惕CDC≥III并发症、术后胰腺出血和再入院风险较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Minimally invasive spleen-preserving distal pancreatectomy (SPDP) presents technical challenges and remains a topic of debate. This study seeks to compare the splenic preservation techniques, especially the Kimura and Warshaw methods, with distal pancreatectomy with splenectomy (DPS) and to examine factors influencing short-term patient prognostic outcomes. METHODS: A retrospective analysis was undertaken of all consecutive cases of minimally invasive distal pancreatectomy, both with and without spleen preservation, conducted at our center from January 2020 to May 2024. The study assessed the impact of demographic characteristics, operative variables, oncologic pathology review, and postoperative outcomes on patients' prognosis. Propensity score matching (PSM) was conducted at a 1:1 ratio. Both univariate and multivariate analyses were performed to identify risk factors affecting the preservation of the spleen and splenic vessels during distal pancreatectomy. RESULTS: The research encompassed data from 490 consecutive patients who underwent minimally invasive distal pancreatectomy. Among the groups with planned spleen-preserving operations, after PSM, the incidence of Clavien-Dindo classification (CDC) ≥ III (6.3% vs. 0.7%, p = 0.010), postoperative pancreatic hemorrhage (4.2% vs. 0%, p = 0.039) and readmission within 90 days (4.2% vs. 0%, p = 0.039) was significantly higher in the Kimura group. Meanwhile, the Kimura group demonstrated a significantly lower incidence of splenic infarction (6.3% vs. 31.3%, p < 0.01) compared to the Warshaw group. Grouped by the minimally invasive methods, the robotic-SPDP (R-SPDP) group exhibited a lower rate of splenic infarction (7.6% vs. 27.5%, p < 0.01), as well as reduced operative time (145 vs. 175 min, p < 0.01) and postoperative hospital stay (6 vs. 8 days, p < 0.01), compared to the laparoscopic-SPDP (L-SPDP) group. An analysis of the minimally invasive technique revealed that the SPDP group experienced a lower rate of pleural effusion (5.6% vs. 16.8%, p = 0.009) than the DPS group after PSM analysis. Univariate analysis identified tumor diameter, operative time, Warshaw technique, and laparoscopic procedure as prognostic factors for the occurrence of splenic infarction. The Warshaw technique and laparoscopic approach were identified as independent prognostic factors for splenic infarction in multivariate analysis. CONCLUSIONS: Both techniques have demonstrated efficacy in minimally invasive SPDP. Our findings indicate that the robotic-assisted Warshaw approach may offer enhanced efficiency and safety.
引用
- Zhou S, Chen MY, Lu Z, et al. Robotic distal pancreatectomy using the Warshaw technique demonstrated superior short-term prognosis compared to the laparoscopic approach: propensity-matched cohort study. Surg Endosc. 2025. PMID: 40140082. doi:10.1007/s00464-025-11686-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。